Recently our GH AMEA leaders Simranjit Singh, CEO and Jasmeet (Jasmine) Kaur, Head of Government and Corporate Affairs attended the World Economic Forum – Summer Davos Meeting of New Champions in Tianjin.

“We’re excited about the huge opportunity for growth in innovative drug development. Especially with our strategic partnership with Adicon Clinical Laboratories, Inc., one of the largest clinical reference labs in China to set up Guardant Health’s Best in Class, FDA-approved Liquid Biopsy platforms for Biopharma clinical trials and R&D in China,” said Simranjit Singh, CEO GH AMEA. Click Simran’s post to learn more about his insights and experiences from #WEF #AMNC23.

Visit https://lnkd.in/gHNdYtQN to find out more about our comprehensive genomic profiling tests which can help guide treatment decisions for patients with cancer.

#GuardantHealthAMEA #MedicalOncologists #NGS